Tissue Engineering

Cultivated Meat Scale-Up Market to Hit $5.6 Billion by 2036
Biotech & Bioprocessing Cultivated Meat Scale-Up Market to Hit $5.6 Billion by 2036

The global food production landscape is currently undergoing a radical metamorphosis as cultivated meat moves from high-concept laboratory prototypes into the realm of multi-ton industrial manufacturing facilities. This transition signifies the emergence of a specialized infrastructure specifically

Can Regenerative Medicine Reverse Parkinson’s Disease?
Biotech & Bioprocessing Can Regenerative Medicine Reverse Parkinson’s Disease?

The progressive loss of dopamine-producing neurons in the substantia nigra remains one of the most daunting challenges in modern neurology, affecting millions of lives worldwide today. Conventional treatments, such as levodopa, served as the gold standard for managing motor symptoms, yet these

Are Bioengineered Vessels the Future of Vascular Surgery?
Biotech & Bioprocessing Are Bioengineered Vessels the Future of Vascular Surgery?

Trauma surgeons often face a race against time when a patient presents with a shattered limb or a ruptured artery where every second spent searching for a viable donor vein increases the risk of amputation or death. This high-pressure environment has long necessitated a surgical solution that

Tensive Reports Success for REGENERA Breast Scaffold Trial
Management & Regulatory Tensive Reports Success for REGENERA Breast Scaffold Trial

The pursuit of surgical solutions that prioritize long-term biological compatibility has led to a breakthrough in the field of soft tissue reconstruction with the successful completion of the latest clinical trials for the REGENERA breast scaffold. Unlike traditional synthetic implants that remain

Trial Strategy Is Key for Spinal Cord Injury Cell Therapy
Biotech & Bioprocessing Trial Strategy Is Key for Spinal Cord Injury Cell Therapy

The scientific pursuit of restoring motor and sensory function to patients suffering from traumatic spinal cord injuries has recently transitioned from a purely exploratory endeavor into a rigorous exercise in clinical trial strategy and logistical precision. While the biological potential of

Industrializing Organoids Powers AI-Driven Drug Discovery
Tech & Innovation Industrializing Organoids Powers AI-Driven Drug Discovery

The pharmaceutical industry stands at a peculiar crossroads where artificial intelligence can dream up millions of promising new drug candidates in hours, yet the actual biological validation of these molecules still relies on antiquated systems that often take months to yield actionable results.

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later